Volume 2, Problème 3 (2012)
Mise à jour de la recherche
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey
Entretien
Perspective on Adaptive Designs: 4 years European Medicines Agency reflection paper, 1 year draft US FDA guidance: where are we now?
Brenda Gaydos, Armin Koch, Frank Miller, Martin Posch, Marc Vandemeulebroecke, Sue-Jane Wang
Perspective thérapeutique
Therapeutic potential of c-MET inhibitors: background and clinical data
Shawna Leslie Organ, J Rafael Sierra,Ming-Sound Tsao
Perspective du parcours clinique
Statistical design and analysis issues for the ARDS clinical trials network: the Coordinating Center perspective
David Schoenfeld
Perspective du parcours clinique
Assessment of suicidal ideation and behavior in clinical trials: challenges & controversies
Glenn Melvin
Mise à jour de la recherche
Developing a multidisciplinary network for clinical research on HIV infection: the EuroCoord experience
Frank de Wolf, Caroline Sabin, Ole Kirk, Claire Thorne, Genevieve Chene,Kholoud Porter
Examen : Résultats de l'essai clinique
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Rapport spécial
The views of older people and carers on participation in clinical trials: the PREDICT Study
Frank Balis
Perspective du parcours clinique
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
